Bowen Xue Associate Corporate Bowen advises clients on a broad variety of corporate matters, including mergers and acquisitions and venture capital financings.
Experience Fenwick Represents Day One Biopharmaceuticals in $184M Initial Public Offering June 2, 2021
Publications SEC Announces Latest Amendments to Proxy Advisor Rules Will Not Be Enforced, Pending Additional Review June 2, 2021
